Dry-type analysis reagent sheet for glutamic oxalacetic transaminase detection

By introducing a prereaction layer and an inorganic solvent into the dry analysis reagent tablets, the problems of low detection accuracy and environmental pollution in the prior art are solved, and a high accuracy and environmentally friendly glutinous aminotransferase detection is achieved, which is suitable for clinical biochemical detection.

CN119040110APending Publication Date: 2024-11-29LUCKY HEALTHCARE CO LTD
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411063282.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-14
Publication Date
2024-11-29

AI Technical Summary

Technical Problem

The existing dry-type glutinous aminotransferase detection methods have problems such as low detection accuracy, uncontrollable reaction sequences and unfriendly environments. In particular, the lack of prereaction layer in the reagent tablet technology leads to inaccurate detection results.

Method used

A dry analytical reagent tablet consisting of a support layer, a diffusion layer, a prereaction layer and a reagent layer is designed, and the prereaction layer is composed of a water-soluble polymer and a chemical reagent involved in the reaction, for controlling Reaction sequence and avoid environmental pollution through the use of inorganic solvents.

Benefits of technology

It improves detection accuracy and result accuracy, is suitable for clinical biochemical testing, and is environmentally friendly in the production process. The connection between the diffusion layer and the reagent layer is enhanced, which avoids powder falling off and enhances the reliability of the detection.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure FT_1
    Figure FT_1
  • Figure FT_2
    Figure FT_2
  • Figure FT_3
    Figure FT_3
Patent Text Reader

Abstract

According to the dry-type analysis reagent sheet for glutamic oxalacetic transaminase detection, a pre-reaction layer is additionally arranged between a diffusion layer and a reagent layer, and reaction substances fixed on the pre-reaction layer comprise alpha-ketoglutarate sodium, pyridoxal phosphate, sodium aspartate, a surfactant, an activating agent, a stabilizing agent, a buffer solution and a water-soluble high-molecular polymer, reactants fixed on the reagent layer comprise a surfactant, pyruvate oxidase, oxaloacetic acid decarboxylase, peroxidase, a colorless dye, a buffer solution, an auxiliary factor and a water-soluble high-molecular polymer. According to the invention, the pre-reaction layer is arranged between the diffusion layer and the reaction layer, so that specific reaction of glutamic oxalacetic transaminase is firstly carried out on the pre-reaction layer without being interfered by substances of other layers, an effect of controlling a reaction sequence is achieved, the diffusion layer and the reagent layer can be tightly connected together by the pre-reaction layer, and powder of the diffusion layer is prevented from falling off.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a dry analysis reagent tablet, in particular to a dry analysis reagent tablet for detecting aspartate aminotransferase, and belongs to the technical field of clinical diagnosis. Background Art

[0002] Aspartate aminotransferase (GOT) is an enzyme present in various tissues of the human body. Its main clinical significance lies in evaluating the health of the liver. When the liver is damaged or affected by disease, a large amount of GOT will be released from liver cells into the blood, resulting in an increase in the level of GOT in the blood. Therefore, measuring the level of GOT in the blood is an important method for evaluating liver function and diagnosing liver disease.

[0003] Clinical detection methods for aspartate aminotransferase are divided into wet chemistry and dry chemistry. Wet chemistry is a commonly used analytical method. The reagents can be prepared once to analyze a large number of clinical samples at the same time. However, with the increase in the demand for emergency testing, the clinical report time for biochemical analysis has put forward shorter requirements, which has promoted the development of emergency biochemical testing technology from traditional wet chemistry to dry biochemistry. Compared with conventional wet chemical analysis methods, dry chemical analysis methods have the advantages of fast detection speed, easy storage of detection reagents, no need to configure any liquid reagents, low detection threshold requirements, and strong adaptability to occasions. According to the test needs, scattered samples can be tested for personalized project combinations anytime and anywhere, which is especially suitable for emergency, primary clinics, blood stations, physical examination institutions, testing laboratories and other scenarios.

[0004] At present, the commonly used dry detection technology is divided into test strips and reagent sheets. The technology of test strips adopts an immersion method to immerse the test paper in a reagent solution. This technology cannot control the amount of drug added, resulting in insufficient detection accuracy. The detection is mostly qualitative and semi-quantitative, which cannot meet clinical detection; and the reagent sheet technology only sets a reaction layer, and the reaction sequence cannot be controlled. The patent with publication number CN102288747B discloses a reagent strip for determining aspartate aminotransferase. This method is more complicated and cannot achieve highly quantitative analysis, which is not suitable for clinical detection. The patent with publication number US4547460A discloses a reagent dry sheet for determining aspartate aminotransferase, and its diffusion layer is prepared using an organic solvent system, which is not environmentally friendly. The patent with publication number CN114002422A discloses a multilayer membrane dry chemical reagent sheet for biochemical analysis. This method does not design a pre-reaction layer, cannot control the reaction sequence, and reduces the detection accuracy. Summary of the invention

[0005] In order to overcome the drawbacks of the prior art, the present invention provides a dry analytical reagent sheet for detecting aspartate aminotransferase, in which a pre-reaction layer is arranged between the diffusion layer and the reaction layer, so that the aspartate aminotransferase undergoes a specific reaction in the pre-reaction layer without being interfered by materials in other layers, thereby playing a role in controlling the reaction sequence, and the layer can tightly connect the diffusion layer and the reagent layer together to prevent the diffusion layer powder from falling off.

[0006] The technical solution adopted by the present invention to solve its technical problem is:

[0007] A dry analytical reagent sheet for detecting aspartate aminotransferase, the dry analytical reagent sheet comprising, from top to bottom, an upper support layer, a diffusion layer, a pre-reaction layer, a reagent layer, a support body and a lower support layer, the diffusion layer, the pre-reaction layer, the reagent layer and the support body are arranged in a middle position between the upper support layer and the lower support layer in sequence from top to bottom, the pores at both ends of the upper support layer and the lower support layer are bonded by the middle support layer, the middle positions of the upper support layer and the lower support layer are respectively provided with a sample addition hole and a test hole, the reaction substances fixed on the pre-reaction layer include sodium α-ketoglutarate, pyridoxal phosphate, sodium aspartate, a surfactant, an activator, a stabilizer, a buffer and a water-soluble high molecular polymer, and the reactants fixed on the reagent layer include a surfactant, pyruvate oxidase, oxaloacetate decarboxylase, peroxidase, a colorless dye, a buffer, an auxiliary factor and a water-soluble high molecular polymer.

[0008] In the above-mentioned dry analytical reagent sheet for detecting aspartate aminotransferase, the diffusion layer is an isotropic porous diffusion membrane with a porosity of 50-85%; the substances fixed in the diffusion layer include polymer microspheres, adhesives and surfactants.

[0009] The dry analytical reagent sheet for detecting aspartate aminotransferase described above, the adhesive is a styrene-acrylic emulsion prepared by copolymerization of acrylic acid and styrene monomers, wherein the usage ratio of acrylic acid to styrene is 50:50.

[0010] The above-mentioned dry analytical reagent sheet for aspartate aminotransferase detection, the polymer microspheres include one of polystyrene, poly(styrene-methacrylic acid), poly(styrene-divinylbenzene), polymethyl methacrylate, poly(methyl methacrylate-butyl acrylate), poly(styrene-butyl acrylate), poly(methylstyrene-tert-butylstyrene-methacrylic acid) and poly(styrene-hydroxyethyl methacrylate-divinylbenzene).

[0011] In the above-mentioned dry analytical reagent sheet for aspartate aminotransferase detection, the component of the water-soluble high molecular polymer in the pre-reaction layer is a mixture of one or more of polyvinyl pyrrolidone, agarose, dextran, polyvinyl alcohol, polyacrylamide, and hydrophilic cellulose derivatives; and the water-soluble high molecular polymer in the reagent layer is gelatin.

[0012] In the above-mentioned dry analytical reagent tablet for detecting aspartate aminotransferase, the activator is one or more of magnesium chloride, magnesium sulfate, calcium chloride, and calcium sulfate; the stabilizer is one or more of ascorbic acid oxidase, EDTA, polyethylene glycol, magnesium chloride, and sodium cholate.

[0013] The above-mentioned dry analytical reagent sheet for aspartate aminotransferase detection, the pH value of the buffer solution in the pre-reaction layer and the reagent layer is 5.0-9.0, which contains tris (hydroxymethyl) aminomethane (tris), phosphate, borate, citric acid or citrate, lysine, N, N-bis (2-hydroxyethyl) glycine, sodium salt or potassium salt of N-2-hydroxyethylpiperazine-N'-2-hydroxypropane-3-sulfonic acid, sodium salt or potassium salt of N-2-hydroxyethylpiperazine-N'-3-sulfonic acid and one of the acids, bases or salts combined with any of the above compounds.

[0014] In the above-mentioned dry analytical reagent sheet for aspartate aminotransferase detection, the surfactant in the pre-reaction layer is one of octylphenoxy polyoxyethylene ether, nonylphenoxy polyoxyethylene ether, polyoxyethylene lauryl ether, Triton X-100 and TritonX-405; the surfactant in the reagent layer is one of Triton X-100, Triton X-102, Triton X-165, Triton X-305 and Triton X-405; the surfactant in the diffusion layer is one of Triton X-100, Triton X-104, alkylphenol polyoxyethylene ether and alkyl alcohol amide.

[0015] In the above-mentioned dry analytical reagent sheet for detecting aspartate aminotransferase, the colorless dye is one of diarylimidazole dye, triarylimidazole dye and benzidine; the auxiliary factor is one or more of flavin adenine dinucleotide, cocarboxylase and acetaminophen.

[0016] The above-mentioned dry analytical reagent sheet for aspartate aminotransferase detection, the upper support layer, the lower support layer and the middle support layer are all transparent plastic substrates with a transmittance of more than 85% under 300nm-800nm ​​wavelength light, including one of polyethylene terephthalate, polycarbonate, polypropylene and polyethylene, and the thickness is 80-250μm, preferably 150-200μm.

[0017] The beneficial effects of the present invention are:

[0018] The present invention adds a pre-reaction layer between the reagent layer and the diffusion layer, which is composed of water-soluble materials and chemical reagents participating in the reaction. The main reactants include sodium α-ketoglutarate, pyridoxal phosphate, and sodium aspartate. These three are the reactants in the first step reaction in the detection principle, and can react with aspartate aminotransferase alone. It is not interfered by other layer materials, and the reaction sequence can be better controlled. The pre-reaction layer can strengthen the connection between the diffusion layer and the reagent layer, and improve the detection accuracy. The diffusion layer of the present invention does not contain organic solvents, and the production and preparation process is environmentally friendly. The reagent sheet of the present invention can be uniformly diffused, and the test result has high accuracy, which is suitable for clinical biochemical detection. BRIEF DESCRIPTION OF THE DRAWINGS

[0019] Figure 1 This is a schematic diagram of the sheet structure of the dry analytical reagent of the present invention;

[0020] Figure 2 It is a correlation curve diagram of Example 1 and the analysis of multiple test samples using the IFCC method;

[0021] Figure 3 is a correlation curve diagram of Example 2 and analysis of multiple test samples using the IFCC method;

[0022] Figure 4 It is a correlation curve diagram of Example 3 and the analysis of multiple test samples using the IFCC method.

[0023] In the figure: 1, upper support layer; 1-1, sample addition hole; 2, diffusion layer; 3, pre-reaction layer; 4, reagent layer; 5, support body; 6, lower support layer; 6-1, test hole; 7, middle support layer. DETAILED DESCRIPTION

[0024] In order to make the purpose, technical solution and advantages of the embodiments of the present invention clearer, the technical solution in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0025] The dry analytical reagent sheet for detecting aspartate aminotransferase of the present invention can measure aspartate aminotransferase in a body fluid sample. The body fluid may be blood or urine, etc. As the body fluid sample, blood or urine may be used directly, or a sample that has been appropriately pretreated may be used.

[0026] See also Figure 1The dry analytical reagent sheet for detecting aspartate aminotransferase of the present invention comprises, from top to bottom, an upper support layer 1, a diffusion layer 2, a pre-reaction layer 3, a reagent layer 4, a support body 5 and a lower support layer 6. The diffusion layer, the reagent layer and the support body are arranged in the middle position between the upper support layer and the lower support layer from top to bottom. The pores at both ends of the upper support layer and the lower support layer are bonded by the middle support layer 7. The middle positions of the upper support layer 1 and the lower support layer 6 are respectively provided with a sample addition hole 1-1 and a test hole 6-1. The reagent layer and the diffusion layer distributed on the support body are structural layers for dripping and diffusing the sample to be tested and generating a biochemical reaction. The support body layer is a structural layer that plays a supporting role and is a light-transmitting carrier. The upper support layer, the lower support layer and the middle support layer are inner packaging structures that play a role in fixing and protecting the support body on which the reagent layer and the diffusion layer are distributed.

[0027] The diffusion layer is an isotropic porous diffusion membrane with a porosity of 50-85%. The wet film thickness of the diffusion layer is 60-600 μm, and the dry film thickness after drying at 10°C-60°C is 50-300 μm. The diffusion layer is composed of polymer microspheres, adhesives and surfactants. The polymer microspheres are preferably polystyrene microspheres. The particle size of the polystyrene microspheres is 20-60 μm, and the amount added per unit square meter is 30-600 g, preferably 50-400 g. The amount of the adhesive added per unit square meter accounts for 1-20% of the amount of the polystyrene microspheres added per unit square meter. In this way, an isotropic porous diffusion layer with different porosities and pore size distributions is controlled to be formed, which is used for rapid absorption, uniform distribution, metering and rapid transmission of multiple analytes, thereby analyzing substances to be tested with different molecular weight distributions and compositions in biological fluids.

[0028] The pre-reaction layer mainly plays the role of controlling the reaction sequence and strengthening the connectivity between the diffusion layer and the reagent layer. The main substances include reactants, activators, stabilizers, buffer solutions and water-soluble high molecular polymers. The reactants include sodium α-ketoglutarate, pyridoxal phosphate and sodium aspartate. The added amounts per unit square meter are 0.5-10g, 0.01-1g and 1-10g respectively. These three are the reactants in the first step reaction in the detection principle, and can react specifically with aspartate aminotransferase alone without interference from other layers of substances, thereby playing the role of controlling the reaction sequence.

[0029] The water-soluble high molecular polymer component of the pre-reaction layer is a mixture of one or more of polyvinyl pyrrolidone, agarose, dextran, polyvinyl alcohol, polyacrylamide, and hydrophilic cellulose derivatives, preferably polyvinyl pyrrolidone, and the usage amount is 1-50g per unit square meter, preferably 5-20g per unit square meter. PVP is easily soluble in water at room temperature and has viscosity. When the diffusion layer solution is applied on the PVP layer, a small amount of PVP will dissolve in the diffusion layer, thereby improving the connectivity between the diffusion layer and the PVP layer, that is, strengthening the connection between the diffusion layer and the reagent layer.

[0030] The surfactant component of the pre-reaction layer is one of octylphenoxy polyoxyethylene ether, nonylphenoxy polyoxyethylene ether, polyoxyethylene lauryl ether, Triton X-100 and Triton X-405, and the added amount per unit square meter is 0.1-10g.

[0031] The activator of the pre-reaction layer is one or more of magnesium chloride, magnesium sulfate, calcium chloride, and calcium sulfate, and the amount added per unit square meter is 0.1-10g. The stabilizer is one or more of ascorbic acid oxidase, EDTA, polyethylene glycol, magnesium chloride, and sodium cholate, and the amount added per unit square meter is 0.01-20g.

[0032] The buffer solution of the pre-reaction layer has a pH value of 5.0-9.0, and contains tris(hydroxymethyl)aminomethane (tris), phosphate, borate, citric acid or citrate, lysine, N,N-bis(2-hydroxyethyl)glycine, sodium salt or potassium salt of N-2-hydroxyethylpiperazine-N'-2-hydroxypropane-3-sulfonic acid, sodium salt or potassium salt of N-2-hydroxyethylpiperazine-N'-3-sulfonic acid, sodium salt or potassium salt of N-[tris(hydroxymethyl)methyl]-3-aminopropane sulfonic acid, sodium salt or potassium salt of N-2-hydroxyethylpiperazine-N'-2-ethane sulfonic acid, and one of the acids, bases or salts combined with any of the above compounds.

[0033] The reagent layer includes a surfactant, pyruvate oxidase, peroxidase, oxaloacetate decarboxylase, phosphate, auxiliary factors, buffer, colorless dye and water-soluble high molecular polymer. The colorless dye (color substrate) is selected from 2-(3,5-dimethoxy-4-hydroxyphenyl)-4,5-p-(4-dimethylaminophenyl)imidazole. It can specifically bind to hydrogen peroxide generated by enzyme-linked reaction in the same molar ratio (1:1) to generate a high-density concentration of color-developing substances, thereby improving the accurate detection range of aspartate aminotransferase.

[0034] The surfactant in the reagent layer can be purchased from Rohm and Haas Co. under the Triton trademark (X-100, 102, 165, 305 and 405 are particularly useful), preferably Triton X-100, and the amount added per unit square meter is 0.01-25g, more preferably 0.1-10g per unit square meter.

[0035] There is no limitation on the sources of pyruvate oxidase, peroxidase and oxaloacetate decarboxylase in the reagent layer, and the usage amount is 0.5-50KU, 0.1-80KU, 0.5-100KU per square meter, preferably 1-10KU, 1-20KU, 2-20KU per square meter.

[0036] The phosphate in the reagent layer, typical phosphates include sodium monohydrogen phosphate, sodium dihydrogen phosphate, sodium phosphate, potassium monohydrogen phosphate, potassium dihydrogen phosphate and potassium phosphate, and the usage amount is 0.002-5g per unit square meter, preferably 0.1-1g per unit square meter.

[0037] The buffer in the reagent layer is preferably a phosphate buffer or a Tris buffer. The pH value of the buffer is determined according to the activity range of the enzyme used and is adjusted to pH 5.0-9.0, preferably adjusted to pH 6.5-8.5.

[0038] The auxiliary factor in the reagent layer is preferably flavin adenine dinucleotide, and the usage amount is 0.001-1g per square meter, preferably 0.1-2.5g per square meter.

[0039] The water-soluble high molecular polymer in the reagent layer is preferably gelatin, and the usage amount is 1-50 g per square meter, preferably 2-25 g per square meter.

[0040] The preparation method of the present invention:

[0041] (1) Reagent Layer The reagent solution is coated on the support. The coating method can be a known method, preferably wire rod coating, blade coating, and extrusion coating. The wet film thickness of the reagent layer is preferably 50-500 μm. After drying at 10° C.-60° C., the dry film thickness of the reagent layer is preferably 5-50 μm.

[0042] (2) The pre-reaction layer reagent solution is coated on the (1) reagent layer. The coating method can use a known method, preferably wire rod coating, blade coating, and extrusion coating. The wet film thickness of the pre-reaction layer is preferably 50-200 μm. After drying at 10°C-60°C, the dry film thickness of the pre-reaction layer is preferably 5-20 μm.

[0043] (3) The diffusion layer slurry is coated on the (2) pre-reaction layer. The coating method can be a known method, preferably wire rod coating, blade coating, and extrusion coating. The wet film thickness of the diffusion layer is preferably 60-600 μm. After drying at 10° C.-60° C., the dry film thickness of the diffusion layer is preferably 20-200 μm.

[0044] (4) Cut the material prepared in step (3) into 1.2 cm 2 The small pieces are fixed and assembled into dry analytical reagents using customized white PET plastic sheets as the upper support layer, the lower support layer and the middle support layer.

[0045] The dry analytical reagent detection method for aspartate aminotransferase of the present invention is as follows:

[0046] About 5 μL-25 μL of the liquid to be tested is dripped onto the porous diffusion layer of various homogeneity, and incubated for 1 minute to 15 minutes under a constant temperature condition of about 25℃-50℃. The liquid to be tested quickly diffuses uniformly in four directions through the diffusion layer and diffuses longitudinally to the reagent layer to form a uniform concentration distribution. The aspartate aminotransferase reacts with sodium α-ketoglutarate and sodium aspartate under the catalysis of pyridoxal phosphate to generate oxaloacetic acid, and generates pyruvic acid under the catalysis of oxaloacetic acid decarboxylase. Under the action of pyruvate oxidase, pyruvic acid reacts with phosphate and oxygen to generate hydrogen peroxide, and hydrogen peroxide reacts with a colorless dye under the catalysis of peroxidase to generate a complex of a specific color. The reflection density detection is carried out on the color change reaction produced by the dry analytical reagent from the support side, and the concentration of aspartate aminotransferase in the liquid to be tested is calculated using a pre-made calibration curve. The equation for the reaction of the target substance aspartate aminotransferase with the corresponding substance in the dry analytical reagent is as follows:

[0047]

[0048] The preparation process of the dry analytical reagent for detecting aspartate aminotransferase of the present invention does not require an organic solvent and is environmentally friendly. The dry analytical reagent has good stability, is easy to store and preserve, has high detection accuracy, and has a wide linear range.

[0049] The present invention will be further described below in conjunction with the embodiments.

[0050] The layer thickness in the following examples refers to the dry film layer thickness.

[0051] Example 1

[0052] The reagent layer, pre-reaction layer and diffusion layer as shown in Table 1 are coated on a colorless and transparent 175 μm PET film support 5, wherein there are two groups, A and B, respectively. Group A has no pre-reaction layer (reagent composition as shown in Table 1), and the reagent layer thickness is 10 μm. Group B has a pre-reaction layer (reagent composition as shown in Table 2), the reagent layer thickness is 10 μm, and the pre-reaction layer thickness is 20 μm. After the production is completed, it is cut into 1.2 cm 2 Then use a white PET plastic sheet as the upper support layer 1, the lower support layer 6 and the middle support layer 7. After assembly, it can be used for measurement.

[0053] Table 1 Composition of reagents for determination of aspartate aminotransferase in group A

[0054]

[0055]

[0056] Table 2 Composition of reagents for determination of aspartate aminotransferase in group B

[0057]

[0058] The two groups of reagent sheets A and B were tested with serum of different concentrations, and the test results are shown in Table 3. It can be seen that after adding the pre-reaction layer, the test results are closer to the true value than without the pre-reaction layer.

[0059] Table 3 Test results of two groups of reagent tablets A and B

[0060] ALT serum value (U / L) Group A(U / L) Group B (U / L) 20 15 18 45 41 43 80 76 78 100 94 98 300 292 297 400 391 397 600 592 596 800 790 795 950 938 944

[0061] For the group B experiment of the present invention, 50 clinical serum samples were used to compare the correlation between the method of the present invention and the analysis of multiple test samples using the IFCC method. The results are as follows: Figure 2 As shown. Among them, R 2 Represents the relevance of the method, R 2 The larger the value, the better the correlation. 2 The maximum value can be 1, indicating perfect correlation. 2 It is 0.9985, indicating that the method has good correlation.

[0062] As shown in the above results, after adding the pre-reaction layer, the detected result is closer to the real serum value compared with the absence of the pre-reaction layer. This is because the diffusion layer in Group A is not tightly combined with the gelatin coating of the reagent layer, which will cause the diffusion layer powder to fall off, and the serum does not smoothly enter the reagent layer from the diffusion layer to react, so the reaction is incomplete. The presence of the pre-reaction layer of the present invention strengthens the connectivity of the diffusion layer and the reagent layer, causing the diffusion layer powder to be difficult to fall off, and the serum can smoothly reach the pre-reaction layer from the diffusion layer to react, and the substance generated by the reaction reacts with the substance of the reagent layer again, and finally reacts completely and obtains the result. Therefore, the result of the coating containing the pre-reaction layer is closer to the true value.

[0063] Example 2

[0064] The reagent layer, pre-reaction layer and diffusion layer composed of the following Table 4 are coated on a colorless and transparent 175 μm PET film support 5, wherein there are two groups, C and D, respectively. The pH of the buffer solution in group C is 4.5, the thickness of the reagent layer is 10 μm, and the thickness of the pre-reaction layer is 8 μm. The pH of the buffer solution in group D is 8.5, the thickness of the reagent layer is 10 μm, and the thickness of the pre-reaction layer is 8 μm. After the production is completed, it is cut into 1.2 cm 2 Then use a white PET plastic sheet as the upper support layer 1, the lower support layer 6 and the middle support layer 7. After assembly, it can be used for measurement.

[0065] Table 4 Reagent composition at different pH values

[0066]

[0067]

[0068] The two groups of reagent tablets C and D were tested with serum of different concentrations, and the test results are shown in Table 5. It can be seen that the value detected at pH 8.5 is closer to the true value than the value detected at pH 4.5. This is because the activity of aspartate aminotransferase is relatively stable and has higher activity when the pH is between 7.0 and 8.5, and the pH 4.5 has more deviations, so the detection value deviation is larger.

[0069] Table 5 Test results of two groups of reagent tablets C and D

[0070] ALT serum value (U / L) Group C (U / L) Group D (U / L) 20 12 21 45 34 49 80 70 74 100 89 98 300 281 293 400 383 390 600 579 585 800 776 779 950 911 925

[0071] For the D group experiment of the present invention, 50 clinical serum samples were used to compare the correlation between the method of the present invention and the analysis of multiple test samples using the IFCC method. The results are as follows: Figure 3 As shown. It can be seen that the R 2 It is 0.996, indicating that the method has good correlation.

[0072] Example 3

[0073] The reagent layer, pre-reaction layer and diffusion layer of the following Table 6 are coated on a colorless and transparent 175 μm PET film support 5, wherein there are two groups, E and F, respectively. The thickness of the reagent layer of group E is 10 μm, the thickness of the pre-reaction layer is 1 μm, and the thickness of the reagent layer of group F is 10 μm, and the thickness of the pre-reaction layer is 8 μm. After the production is completed, it is cut into 1.2 cm 2 Then use a white PET plastic sheet as the upper support layer 1, the lower support layer 6 and the middle support layer 7. After assembly, it can be used for measurement.

[0074] Table 6 Reagent composition of different pre-reaction layer thicknesses

[0075]

[0076] The two groups of reagent sheets E and F were tested with serum of different concentrations, and the test results are shown in Table 7. It can be seen that the value detected when the pre-reaction layer thickness is 8 μm is closer to the true value than the value detected when the pre-reaction layer thickness is 1 μm. This is because when the thickness is 1 μm, the substance in the pre-reaction layer is too thin and cannot be stably present in the pre-reaction layer, and precipitation will occur, resulting in unstable performance of the drug, so the detection value deviation is large.

[0077] Table 7 Test results of two groups of reagent tablets E and F

[0078] ALT serum value (U / L) Group E(U / L) Group F (U / L) 20 12 19 45 33 43 80 64 78 100 82 98 300 268 294 400 363 395 600 542 595 800 763 794 950 906 943

[0079] For the F group experiment of the present invention, 50 clinical serum samples were used to analyze the correlation between the method of the present invention and the IFCC method for analyzing multiple test samples. The results are as follows: Figure 4 As shown. It can be seen that the R 2 It is 0.9971, indicating that the method has good correlation.

[0080] The above embodiments are only for illustrating the technical concept and features of the present invention, and their purpose is to enable ordinary technicians in the field to understand the content of the present invention and to rely on facts, and they cannot be used to limit the protection scope of the present invention. Any equivalent replacement or improvement made based on the essence of the content of the present invention should be included in the scope of the claims of the present invention.

Claims

1. A dry analytical reagent tablet for detecting aspartate aminotransferase, characterized in that: The dry analytical reagent sheet comprises, from top to bottom, an upper support layer (1), a diffusion layer (2), a pre-reaction layer (3), a reagent layer (4), a support body (5) and a lower support layer (6); the diffusion layer (2), the pre-reaction layer (3), the reagent layer (4) and the support body (5) are arranged in a middle position between the upper support layer (1) and the lower support layer (6) from top to bottom; the pores at both ends of the upper support layer (1) and the lower support layer (6) are bonded by an intermediate support layer (7); the upper support layer (1) ) and a lower support layer (6) are respectively provided with a sample loading hole (1-1) and a test hole (6-1), the reaction substances fixed on the pre-reaction layer (3) include sodium α-ketoglutarate, pyridoxal phosphate, sodium aspartate, a surfactant, an activator, a stabilizer, a buffer and a water-soluble polymer, and the reactants fixed on the reagent layer (4) include a surfactant, pyruvate oxidase, oxaloacetate decarboxylase, peroxidase, a colorless dye, a buffer, an auxiliary factor and a water-soluble polymer.

2. The dry analytical reagent sheet for detecting aspartate aminotransferase according to claim 1, characterized in that: The diffusion layer (2) is an isotropic porous diffusion membrane with a porosity of 50-85%. The substances fixed in the diffusion layer include polymer microspheres, adhesives and surfactants.

3. The dry analytical reagent sheet for detecting aspartate aminotransferase according to claim 2, characterized in that: The adhesive is a styrene-acrylic emulsion prepared by copolymerization of acrylic acid and styrene monomers, wherein the usage ratio of acrylic acid to styrene is 50:

50.

4. The dry analytical reagent sheet for detecting aspartate aminotransferase according to claim 2, characterized in that: The polymer microspheres include one of polystyrene, poly(styrene-methacrylic acid), poly(styrene-divinylbenzene), polymethyl methacrylate, poly(methyl methacrylate-butyl acrylate), poly(styrene-butyl acrylate), poly(methylstyrene-tert-butylstyrene-methacrylic acid) and poly(styrene-hydroxyethyl methacrylate-divinylbenzene).

5. The dry analytical reagent sheet for detecting aspartate aminotransferase according to claim 1, characterized in that: The water-soluble high molecular polymer in the pre-reaction layer (3) is a mixture of one or more of polyvinyl pyrrolidone, agarose, dextran, polyvinyl alcohol, polyacrylamide, and hydrophilic cellulose derivatives; and the water-soluble high molecular polymer in the reagent layer (4) is gelatin.

6. The dry analytical reagent sheet for detecting aspartate aminotransferase according to claim 1, characterized in that: The activator is one or more of magnesium chloride, magnesium sulfate, calcium chloride, and calcium sulfate; the stabilizer is one or more of ascorbic acid oxidase, EDTA, polyethylene glycol, magnesium chloride, and sodium cholate.

7. The dry analytical reagent sheet for detecting aspartate aminotransferase according to claim 1, characterized in that: The pH value of the buffer in the pre-reaction layer (3) and the reagent layer (4) is 5.0-9.0, and it contains tris(hydroxymethyl)aminomethane (Tris), phosphate, borate, citric acid or citrate, lysine, N,N-bis(2-hydroxyethyl)glycine, sodium salt or potassium salt of N-2-hydroxyethylpiperazine-N'-2-hydroxypropane-3-sulfonic acid, sodium salt or potassium salt of N-2-hydroxyethylpiperazine-N'-3-sulfonic acid, and one of the acids, bases or salts combined with any of the above compounds.

8. The dry analytical reagent sheet for detecting aspartate aminotransferase according to claim 2, characterized in that: The surfactant in the pre-reaction layer is one of octylphenoxy polyoxyethylene ether, nonylphenoxy polyoxyethylene ether, polyoxyethylene lauryl ether, Triton X-100 and Triton X-405; the surfactant in the reagent layer is one of Triton X-100, Triton X-102, Triton X-165, Triton X-305 and Triton X-405; the surfactant in the diffusion layer is one of Triton X-100, Triton X-104, alkylphenol polyoxyethylene ether and alkyl alcohol amide.

9. The dry analytical reagent sheet for detecting aspartate aminotransferase according to claim 1, characterized in that: The colorless dye is one of diarylimidazole dye, triarylimidazole dye and benzidine; the auxiliary factor is one or more of flavin adenine dinucleotide, cocarboxylase and acetaminophen.

10. The dry analytical reagent sheet for detecting aspartate aminotransferase according to claim 1, characterized in that: The upper support layer, the lower support layer and the middle support layer are all transparent plastic substrates with a light transmittance of more than 85% under a wavelength of 300nm-800nm, including one of polyethylene terephthalate, polycarbonate, polypropylene and polyethylene, and have a thickness of 80-250μm.

Citation Information

Cited By

  • Method for predicting the level of glutamyl pyruvic transaminase based on machine learning and multi-source clinical data

    CN122991654A